Clinical Trial Update: DDI Study of Etravirine and GSK1265744 [Phase 1]

View source ↗

Summary

A Phase 1 drug-drug interaction study evaluating etravirine with cabotegravir (GSK1265744) in healthy subjects and people with HIV has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Intelence (Etravirine)
• cabotegravir (cabotegravir)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Healthy Subjects, Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED